Loading stock data…
NHI
$71.44+2.01 (+2.90%)
Market ClosedLast close Jun 9
National Health Investors, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
National Health Investors, Inc. in the Real Estate sector is trading at $71.44 with a market capitalization of $3.4B. Wall Street consensus targets $85.75 (8 analysts), implying a +20.0% move over the next 12 months. The stock is currently near its 52-week low of $67.94, remaining 8.3% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 33) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$71.44
Potential Upside
1.5%
Whystock Fair Value$72.50
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus8 analysts
Buy
Mean target$85.75+20.0%
Range$74.00 – $91.00
Fundamentals
National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical facility investments. NHI's por...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.37B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.43
Beta
Defensive asset. Lower volatility than the S&P 500.
0.58
Div Yield
Strong income play. Yield provides a meaningful total return floor.
5.12%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.78%
Volume
Today's trading volume
418,934
Recent News
A Look At National Health Investors (NHI) Valuation After Recent Share Price Pullback
Recent performance and income profile National Health Investors (NHI) has drawn attention after a recent share price pullback, with the stock down about 3% over the past day, 4% over the past week and month, and 16% over the past 3 months. The company operates as a self managed real estate investment trust focused on senior housing and medical facilities in the United States. It generates US$404.711m in revenue and US$147.887m in net income across its portfolio. See our latest analysis for...
SHO vs. NHI: Which Stock Is the Better Value Option?
SHO vs. NHI: Which Stock Is the Better Value Option?
PEB vs. NHI: Which Stock Is the Better Value Option?
PEB vs. NHI: Which Stock Is the Better Value Option?
Implied Volatility Surging for National Health Investors Stock Options
Investors need to pay close attention to NHI stock based on the movements in the options market lately.
NHI Q1 2026 Earnings Call Transcript
On the call today are Eric Mendelsohn, President and CEO; Kevin Pascoe, Chief Investment Officer; John Spaid, Chief Financial Officer; and David Travis, Chief Accounting Officer. The results as well as notice of the accessibility of this conference call were released after the market closed yesterday in a press release that's been covered by the financial media.